ETF Series Solutions - Range Cancer Therapeutics ETF
LEI: 549300MLI82YH9HOGS11
ETF Series Solutions - Range Cancer Therapeutics ETF
en
Loncar Cancer Immunotherapy ETF
PREVIOUS_LEGAL_NAME
en
c/o The Corporation Trust Company
615 EAST MICHIGAN ST
MILWAUKEE, 53202
UNITED STATES
3555 NW 58th ST
Oklahoma, 53202
UNITED STATES
UNITED STATES (US)
Delaware (US-DE)
Securities and Exchange Commission (RA000665)
S000050740
Other (8888)
Fund
FUND
ACTIVE
2015-10-13 00:00:00
NO_KNOWN_PERSON
NO_KNOWN_PERSON
2018-08-14 00:00:00
RELATIONSHIP_PERIOD
NULL
2023-02-27 16:07:08
2025-05-05 13:37:26
ANNULLED
FULLY_CORROBORATED
SUPPORTING_DOCUMENTS
2015-10-13 00:00:00
RELATIONSHIP_PERIOD
ACTIVE
2015-08-07 01:36:00
2025-05-05 13:37:26
LAPSED
FULLY_CORROBORATED
OTHER_OFFICIAL_DOCUMENTS
2015-08-07 01:36:00
2025-05-05 13:37:26
2025-05-05 13:16:12
LAPSED
PARTIALLY_CORROBORATED
Securities and Exchange Commission (RA000665)
S000050740